Kashmiri endocrinologist shows new medicine reduces liver fat

The research has been published in topmost journal of American Diabetes Association, Diabetes Care and was carried out in Division of Endocrinology and Diabetes, Medanta, The Medicity Hospital Gurugram, India. DrKuchay was the lead researcher for the study.

GK NEWS NETWORK
Srinagar, Publish Date: Jun 12 2018 11:49PM | Updated Date: Jun 13 2018 2:00PM
Kashmiri endocrinologist shows new medicine reduces liver fatSource: http://www.drmohammadkuchay.com/

A research led by Kashmiri endocrinologist, Dr M Shafi Kuchay has found that addition of empagliflozin, a new anti-diabetes medicine, to standard diabetes treatment for patients with type-2 diabetes and non-alcoholic fatty liver disease (NAFLD) produces reductions in liver fat and improvements in liver enzymes.

The research has been published in topmost journal of American Diabetes Association, Diabetes Care and was carried out in Division of Endocrinology and Diabetes, Medanta, The Medicity Hospital Gurugram, India. Dr Kuchay was the lead researcher for the study.

“Fatty liver disease is a public health problem and an increasingly recognised association of diabetes,” said Dr Kuchay, consultant in Medanta. He noted that NAFLD progresses to steatohepatitis (NASH) and eventually to cirrhosis or even cancer in a significant proportion of patients. 

“Pharmacologic treatment modalities are few,” he continued, “No agent is approved by the FDA for treating this condition. Empagliflozin, an antidiabetic drug belonging to the SGLT-2 inhibitor class, has gained popularity in recent years because of its ability to promote weight loss and reduce the rate of cardiac events in high-risk patients with type 2 diabetes”. 

Dr Kuchay and his colleagues randomly assigned 50 patients with type 2 diabetes and NAFLD to treatment with empagliflozin 10 mg daily combined with standard treatment of type 2 diabetes or to standard treatment for diabetes without the addition of empagliflozin. This was an open-label trial that lasted for 20 weeks. 

The addition of empagliflozin to standard diabetes treatment was associated with a reduction in liver fat as measured by MRI-derived proton density fat fraction, with a mean difference between the two groups of 4.0 percent (P<0.0001). 

In addition, there was a significant reduction in liver fat from baseline to the end-of-treatment, from 16.2% to 11.3% (P < 0.0001) among empagliflozin-treated patients. In contrast, among those who did not receive empagliflozin, the reduction in liver fat only trended toward significance (from 16.4% to 15.5%; P = 0.057). 

Those treated with empagliflozin also experienced a 10.9 IU/L greater reduction in alanine aminotransferase (ALT) and a 7.7 IU/L greater reduction in aspartate aminotransferase (AST) than those on standard therapy alone. The difference was only significant for ALT, however (P = 0.005 for ALT and P = 0.212 for AST). There was also a trend towards a greater reduction in gamma-glutamyltranspeptidase with empagliflozin (11 IU/L; P = 0.057). 

“This is the first study that showed that this drug reduces liver fat and if the use of this agent, or others of this class, is confirmed to have beneficial effects on all the stages of NAFLD, it will enable physicians to target multiple complications of diabetes with a single drug,” said Dr. AmbrishMithal, Chairman, Division of Endocrinology and Diabetes, Medanta Hospital. 

He pointed out, however, that it remains to be seen whether empagliflozin treatment will ultimately delay or prevent chronic liver disease in a larger group of patients. It will also be important to evaluate how the agent affects histopathological changes at various stages of fatty liver disease. Finally, it will be interesting to see if fatty liver disease can be addressed using empagliflozin in patients without type 2 diabetes.

This study was earlier presented at the annual meeting of the Endocrine Society, from March 17 to 20, in Chicago, where it was widely covered by international media. Subsequently, it was also published by Medscape, a famous professional website for healthcare providers.

Latest News

  1. Kashmiri people and leadership ready to defend Article 35A at any cost: Mirwaiz
  2. Kashmiri people and leadership ready to defend Article 35A at any cost: Mirwaiz
  1. Rawalpora theft cases solved, burglar arrested: Police
  2. Rawalpora theft cases solved, burglar arrested: Police
  1. Prayer leader arrested for peddling drugs in north Kashmir’s Baramulla
  2. Prayer leader arrested for peddling drugs in north Kashmir’s Baramulla
  1. Video | Sidhu to gift Kashmiri shawl to Imran Khan at his swearing in
  2. Video | Sidhu to gift Kashmiri shawl to Imran Khan at his swearing in
  1. Imran Khan elected 22nd Prime Minister of Pakistan
  2. Imran Khan elected 22nd Prime Minister of Pakistan
  1. Vajpayee cremated with full military honours
  2. Vajpayee cremated with full military honours
  1. Hubble captures dazzling image with 15,000 galaxies
  2. Hubble captures dazzling image with 15,000 galaxies
  1. Man injured in Awantipora grenade blast succumbs
  2. Man injured in Awantipora grenade blast succumbs
  1. Mysterious death of man triggers protests in Rajouri
  2. Mysterious death of man triggers protests in Rajouri
  1. Article 35A: JRL calls shutdown in Jammu and Kashmir on August 26, 27
  2. Article 35A: JRL calls shutdown in Jammu and Kashmir on August 26, 27
  1. Samsung tops India premium smartphone market in 2018 first half
  2. Samsung tops India premium smartphone market in 2018 first half
  1. Yasin Malik leads JRL protest in Srinagar, warns against tinkering with Article 35-A
  2. Yasin Malik leads JRL protest in Srinagar, warns against tinkering with Article 35-A
  1. Tens of thousands of pilgrims descend on Mecca for Hajj 2018
  2. Tens of thousands of pilgrims descend on Mecca for Hajj 2018
  1. Video | Indo-Pak peace greatest tribute to Vajpayee: Farooq Abdullah
  2. Video | Indo-Pak peace greatest tribute to Vajpayee: Farooq Abdullah
  1. Four-member Pakistan delegation to attend Vajpayee's funeral: Report
  2. Four-member Pakistan delegation to attend Vajpayee's funeral: Report
  1. Four civilians injured in Awantipora grenade blast
  2. Four civilians injured in Awantipora grenade blast
  1. Railways' glass-top coach in Kashmir-all dressed up and nowhere to go
  2. Railways' glass-top coach in Kashmir-all dressed up and nowhere to go
  1. Woman shot dead by unknown gunmen in Pulwama village
  2. Woman shot dead by unknown gunmen in Pulwama village
  1. Kerala death toll rises to 154, massive rescue underway
  2. Kerala death toll rises to 154, massive rescue underway
  1. Imran all set to become Pakistan PM as cracks appear within Opposition ranks
  2. Imran all set to become Pakistan PM as cracks appear within Opposition ranks
  1. Pak govt, leaders pay tribute to Vajpayee; say he contributed for 'a change' in bilateral ties
  2. Pak govt, leaders pay tribute to Vajpayee; say he contributed for 'a change' in bilateral ties
  1. Elaborate security arrangements in Delhi for Vajpayee's funeral
  2. Elaborate security arrangements in Delhi for Vajpayee's funeral
  1. Army soldier killed in brief shootout in Handwara in north Kashmir
  2. Army soldier killed in brief shootout in Handwara in north Kashmir
  1. India, Pakistan trade fire along LoC in Poonch in Jammu and Kashmir
  2. India, Pakistan trade fire along LoC in Poonch in Jammu and Kashmir
  1. Clashes erupt during search operation in Hajin; Internet suspended
  2. Clashes erupt during search operation in Hajin; Internet suspended
  1. Kashmir University entrance exam as per schedule today
  2. Kashmir University entrance exam as per schedule today
  1. SSB postpones counselling, document verification scheduled today
  2. SSB postpones counselling, document verification scheduled today
x
This site uses cookies to deliver our services and to show you relevant news and ads. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Service.That's Fine